TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, Davis
About this trial
This study is a comparison of the analgesic efficacy of transversus abdominis plane (TAP) blocks with ropivacaine bolus plus continuous ropivacaine infusion via catheters versus single shot TAP blocks with liposomal bupivacaine.
Eligibility criteria
Qualifiers
Patients ages 18 years or older
Renal Transplant Recipients
Disqualifiers
Patients less than 18 years of age
Pregnant Women
Prisoners
Opioid Tolerant Patients taking more than 30 mg/day of oral morphine equivalent analgesia
Trial design
Treatments tested in this trial
- Ropivacaine Continuous Infusion Catheter
- Single Dose Liposomal Bupivicaine
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov